Information:
Error:
ID
25756
Description
Study ID: 101468/169 Clinical Study ID: 101468/169 Study Title:A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment with Ropinirole CR as Adjunctive Therapy in Patients with Parkinson's Disease who are not Optimally Controlled on L-dopa Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00381472 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Parkinson Disease This is the Week 24 form.
Keywords
Versions (1)
- 9/17/17 9/17/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 17, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Patients Suffering from Parkinsons Disease Week 24 101468/169 NCT00381472
GSK Ropinirole in Patients Suffering from Parkinsons Disease Week 24 101468/169 NCT00381472
Similar models
GSK Ropinirole in Patients Suffering from Parkinsons Disease Week 24 101468/169 NCT00381472
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date of diary day 1
Item
Date of diary day 1
date
C3890583 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Total time asleep
Item
Total time asleep
time
C0040223 (UMLS CUI [1,1])
C0037313 (UMLS CUI [1,2])
C0037313 (UMLS CUI [1,2])
awake time off
Item
Total awake time ’Off’
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0234422 (UMLS CUI [1,2])
awake time On
Item
Total awake time ’On’
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0234422 (UMLS CUI [1,2])
awake time dyskinesias
Item
Total awake time "On" with troublesome dyskinesias
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0013384 (UMLS CUI [1,3])
C0234422 (UMLS CUI [1,2])
C0013384 (UMLS CUI [1,3])
Date of diary day 2
Item
Date of diary day 2
date
C3890583 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Total time asleep
Item
Total time asleep
time
C0040223 (UMLS CUI [1,1])
C0037313 (UMLS CUI [1,2])
C0037313 (UMLS CUI [1,2])
awake time Off
Item
Total awake time ’Off’
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0234422 (UMLS CUI [1,2])
awake time On
Item
Total awake time ’On’
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0234422 (UMLS CUI [1,2])
awake time dyskinesias
Item
Total awake time "On" with troublesome dyskinesias
time
C0040223 (UMLS CUI [1,1])
C0234422 (UMLS CUI [1,2])
C0013384 (UMLS CUI [1,3])
C0234422 (UMLS CUI [1,2])
C0013384 (UMLS CUI [1,3])
Subject Number
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Subject continuation
Item
If the subject is not continuing in the study, do not complete this visit but enter appropriate details on the Study Conclusion page. Continuing?
boolean
C0805733 (UMLS CUI [1])
Adverse Events
Item
Record details of any new adverse events/serious adverse events observed or reported by the subject or any changes to ongoing adverse events in the appropriate Adverse Events/Serious Adverse Events section.
boolean
C0877248 (UMLS CUI [1])
Concomitant Medication
Item
Record any changes to the subject’s concomitant medication or any new medications taken since the last visit in the appropriate Concomitant Medication section.
boolean
C2347852 (UMLS CUI [1])
Item Group
L-DOPA MEDICATION CHANGES
C0023570 (UMLS CUI-1)
C0023570 (UMLS CUI-2)
C0023570 (UMLS CUI-2)
change L-Dopa medication
Item
Has there been any change in dose or frequency of L-Dopa medication since the last visit?
boolean
C0023570 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0023570 (UMLS CUI [1,2])
Item
If Yes, tick the primary reason for change:
integer
C0023570 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0023570 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
CL Item
Reduction required by protocol (starting at dose level 4) (1)
CL Item
Unacceptable dopaminergic side-effect (Record in the Adverse Events section) (2)
CL Item
Loss of efficacy (3)
CL Item
Other, specify (4)
reason for change
Item
Other, specify
text
C0023570 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0023570 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Date sample taken
Item
Date sample taken
date
C0005834 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Date of ECG
Item
Date of ECG
date
C2826640 (UMLS CUI [1])
CL Item
Normal (1)
CL Item
Abnormal - not clinically significant (2)
CL Item
Abnormal - clinically significant (3)
pregnancy test
Item
If subject is female and of childbearing potential a serum pregnancy test must be performed.
boolean
C0032976 (UMLS CUI [1])
Blood Pressure Systolic
Item
Blood Pressure Systolic
integer
C0871470 (UMLS CUI [1])
Blood Pressure Diastolic
Item
Blood Pressure Diastolic
integer
C0428883 (UMLS CUI [1])
Heart Rate
Item
Heart Rate
integer
C0018810 (UMLS CUI [1])
Blood Pressure Systolic
Item
Blood Pressure Systolic
integer
C0871470 (UMLS CUI [1])
Blood Pressure Diastolic
Item
Blood Pressure Diastolic
integer
Heart Rate
Item
Heart Rate
integer
C0018810 (UMLS CUI [1])
Item Group
SUBJECT’S FOOD INTAKE DAY BEFORE PK SAMPLING
C0458244 (UMLS CUI-1)
Date of food diary
Item
Date of food diary
date
C0458244 (UMLS CUI [1,1])
C0458244 (UMLS CUI [1,2])
C0458244 (UMLS CUI [1,2])
Time study medication taken
Item
Time study medication taken
time
C0040223 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Time of finishing breakfast
Item
Time of finishing breakfast
time
C0040223 (UMLS CUI [1,1])
C2698559 (UMLS CUI [1,2])
C2698559 (UMLS CUI [1,2])
Time of finishing lunch
Item
Time of finishing lunch
time
C0040223 (UMLS CUI [1,1])
C2697949 (UMLS CUI [1,2])
C2697949 (UMLS CUI [1,2])
Time of finishing dinner
Item
Time of finishing dinner
time
C0040223 (UMLS CUI [1,1])
C4048877 (UMLS CUI [1,2])
C4048877 (UMLS CUI [1,2])
Item Group
SUBJECT’S FOOD INTAKE ON THE DAY OF PK SAMPLING
C0458244 (UMLS CUI-1)
Date of food diary
Item
Date of food diary
date
C0458244 (UMLS CUI [1,1])
C0458244 (UMLS CUI [1,2])
C0458244 (UMLS CUI [1,2])
Time study medication taken
Item
Time study medication taken
time
C0040223 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
Time of finishing breakfast
Item
Time of finishing breakfast
time
C0040223 (UMLS CUI [1,1])
C2698559 (UMLS CUI [1,2])
C2698559 (UMLS CUI [1,2])
Time of finishing lunch
Item
Time of finishing lunch
time
C0040223 (UMLS CUI [1,1])
C2697949 (UMLS CUI [1,2])
C2697949 (UMLS CUI [1,2])
Time of finishing dinner
Item
Time of finishing dinner
time
C0040223 (UMLS CUI [1,1])
C4048877 (UMLS CUI [1,2])
C4048877 (UMLS CUI [1,2])
Item Group
PHARMACOKINETICS - BLOOD
C0031328 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
C0005767 (UMLS CUI-2)
morning clinic
Item
If week 24 is a morning clinic : A pre-dose blood sample should be taken as soon as possible after the subject arrives at the clinic. The morning dose of study medication should be taken as soon as is practical after this blood sample (please record exact time in the diary card). Record the exact time that the blood sample was taken in the "am" section of the CRF No further blood samples are required at this visit.
boolean
C0178913 (UMLS CUI [1])
afternoon clinic
Item
If Week 24 is an afternoon clinic : A blood sample should be taken during the afternoon clinic between 5 and 10 hours after the morning dose. Record the exact time that the blood sample was taken in the "pm" section of the CRF No further blood samples are required at this visit.
boolean
C0178913 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
Pre-dose Date Sample Taken AM visit
Item
Pre-dose Date Sample Taken AM visit
date
C0439565 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
Pre-dose Actual Time AM visit
Item
Pre-dose Actual Time AM visit
time
C0439565 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
Pre-Dose Attach Sample Identifier Label Here AM visit
Item
Pre-Dose Attach Sample Identifier Label Here AM visit
text
C0439565 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
5-10 hrs Post-dose Date Sample Taken PM visit
Item
5-10 hrs Post-dose Date Sample Taken PM visit
date
C0439568 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
5-10 hrs Post-dose Actual Time PM visit
Item
5-10 hrs Post-dose Actual Time PM visit
time
C0439568 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,3])
Attach Sample Identifier Label Here PM visit
Item
Attach Sample Identifier Label Here PM visit
text
C0439568 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,3])
CLINICAL GLOBAL IMPRESSION
Item
CLINICAL GLOBAL IMPRESSION
boolean
C3639708 (UMLS CUI [1])
Item Group
UNIFIED PARKINSONS DISEASE RATING SCALE
C0030567 (UMLS CUI-1)
C0030567 (UMLS CUI-2)
C0030567 (UMLS CUI-2)
UNIFIED PARKINSONS DISEASE RATING SCALE
Item
UNIFIED PARKINSONS DISEASE RATING SCALE
boolean
C0030567 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,2])
Item Group
PARKINSON’S DISEASE SLEEP SCALE (PDSS)
C0030567 (UMLS CUI-1)
C0030567 (UMLS CUI-2)
C0037313 (UMLS CUI-3)
C0030567 (UMLS CUI-2)
C0037313 (UMLS CUI-3)
PARKINSON’S DISEASE SLEEP SCALE
Item
PARKINSON’S DISEASE SLEEP SCALE
boolean
C0030567 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0037313 (UMLS CUI [1,3])
C0030567 (UMLS CUI [1,2])
C0037313 (UMLS CUI [1,3])
BECK DEPRESSION INVENTORY
Item
BECK DEPRESSION INVENTORY
boolean
C0451022 (UMLS CUI [1])
EPWORTH SLEEPINESS SCALE
Item
EPWORTH SLEEPINESS SCALE
boolean
C3541276 (UMLS CUI [1])
Item Group
PARKINSON’S DISEASE QUALITY OF LIFE QUESTIONNAIRE (PDQ-39)
C0030567 (UMLS CUI-1)
C0030567 (UMLS CUI-2)
C0034380 (UMLS CUI-3)
C0030567 (UMLS CUI-2)
C0034380 (UMLS CUI-3)
PARKINSON’S DISEASE QUALITY OF LIFE QUESTIONNAIRE (PDQ-39)
Item
PARKINSON’S DISEASE QUALITY OF LIFE QUESTIONNAIRE (PDQ-39)
boolean
C0030567 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0034380 (UMLS CUI [1,3])
C0030567 (UMLS CUI [1,2])
C0034380 (UMLS CUI [1,3])
Blinded Dose Level
Item
Blinded Dose Level
integer
C0178602 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Investigational product Container Number
Item
Investigational product Container Number
integer
C3898691 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])
Total number of Tablets Dispensed
Item
Total number of Tablets Dispensed
integer
C0805077 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
Total number of Tablets Returned
Item
Total number of Tablets Returned
integer
C2699071 (UMLS CUI [1,1])
C0039225 (UMLS CUI [1,2])
C0039225 (UMLS CUI [1,2])
Has the subject missed investigational product for more than 3 consecutive days?
Item
Has the subject missed investigational product for more than 3 consecutive days?
boolean
C1321605 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Dispense investigational product
Item
Record dispensing information in the Investigational Product and Compliance sections at the next visit.
boolean
C0947323 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Diary Card
Item
Issue the subject with the week 26 Follow-up Diary Card
boolean
C3890583 (UMLS CUI [1,1])
C3812666 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C3812666 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
No comments